Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 7, 2014; 20(41): 15241-15252
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15241
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15241
Drug | FDA category in pregnancy | Key points about drug safety |
Narcotics | ||
Meperidine | B, but D at term | Repeated use of high dose and prolonged administration can cause respiratory depression and seizures |
Fentanyl | C | It is safe in low doses |
Propofol | B | Generally suggested for use in patients who are sedated with difficulty and in complicated clinical situations |
General anesthetics | ||
Ketamine | B | Data are limited with humans; animal data suggest prolonged use is not safe |
Sedatives | ||
Diazepam | D | Some congenital malformations and mental retardation may be associated with diazepam, the use of diazepam during pregnancy is restricted |
Midazolam | D | As a benzodiazepine member, its use is restricted during pregnancy, especially in the first trimester |
Reversing agents | ||
Naloxone | B | It probably is safe but should be used only in respiratory depression, systemic hypotension, or unresponsiveness in a closely monitored pregnant woman after endoscopy |
Flumazenil | C | Fetal risks are unknown, but it should be given carefully in small doses |
- Citation: Savas N. Gastrointestinal endoscopy in pregnancy. World J Gastroenterol 2014; 20(41): 15241-15252
- URL: https://www.wjgnet.com/1007-9327/full/v20/i41/15241.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i41.15241